SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Amneal Pharmaceuticals Price Target Announced at $27.00/Share by Oppenheimer

Ratings actions from Benzinga: GMT) Amneal Pharmaceuticals Initiated at Outperform by OppenheimerRatings actions from Benzinga

AMRX

Related stories